|
Hemophilia is a life-long disease, but significant advances in prevention of bleeding episodes and treatment means that today those with hemophilia suffer fewer damaging consequences of the illness. Innovations in the production of synthetic factor products have also enhanced safety and reduced complications.
These strides have improved the physical and emotional well-being of patients and reduced disruption to school, work and other activities. With careful management, informed decisions, and early recognition of complications, today most children with hemophilia can lead relatively normal, active and healthy lives.
Transitioning to the Adult Service
When our patients reach adulthood, their care will transfer into the Adult Boston Hemophilia Center service, at Brigham and Women's Hospital. Our institutions are located next to one another in the Longwood Medical Area, and our teams communicate on a regular basis to ensure a smooth transition. Typically, our patients move to the adult service by age 22.
|
